Other Events ·
Dodge & Cox reduced its voting interest in GSK plc to 4.96% as of June 24, 2026, down from a previous position of…
GSKGSK plc
Dodge & Cox reduced its voting interest in GSK plc to 4.96% as of June 24, 2026, down from a previous position of 5.01%. The holding consists of 201,065,668 voting rights, comprising 88,816,040 ordinary shares and 112,249,628 ADRs. GSK plc is a pharmaceutical company that researches, develops, and manufactures vaccines and specialty medicines.